Third Point LLC Invests $37.12 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Third Point LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 385,000 shares of the biotechnology company’s stock, valued at approximately $37,122,000. BioMarin Pharmaceutical accounts for about 0.6% of Third Point […]

Related Keywords

Brian Mueller ,Piper Sandler ,George Eric Davis ,Exchange Commission ,Securities Exchange Commission ,Third Point ,Biomarin Pharmaceutical Inc ,Cantor Fitzgerald ,Nasdaq ,Allspring Global Investments Holdings ,Scotiabank ,International Assets Investment Management ,Canaccord Genuity Group ,Biomarin Pharmaceutical Company Profile ,Biomarin Pharmaceutical ,Free Report ,Marin Pharmaceutical ,Global Investments Holdings ,Assets Investment Management ,Investment Management ,Eric Davis ,Get Free Report ,Genuity Group ,Marin Pharmaceutical Inc ,Visit Holdingschannel ,Biomarin Pharmaceutical Daily ,